InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.13
(
0.00%
)
Bitcoin
66,309.63
(
-0.49%
)
Post# of 32745
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

sanscuba

Send PM Follow Ignore
Followers 6
Posts 570
Boards Moderated 0
Alias Born 03/04/2016

sanscuba

Re: None

Wednesday, 12/25/2019 8:26:13 PM

Wednesday, December 25, 2019 8:26:13 PM

Post# of 32745
https://www.businesswire.com/news/home/20181204005563/en/Cerebain-Initiates-Repositioning-Review-Business-Corporate-Strategic?fbclid=IwAR3Rdan8MsN44FGnAePQQbt9kpueY0iGEydB8K1W0vVhBDKawE9l1oSPHTU

Either the close of this month or next month....penny stock and bio-tech company Cerebain (CBBT) is scheduled to POP, POP, POP....pending 3 items: 1) FDA approval for their Alzheimers device and drug that have worked in all three of their clinical phases.....2) Possible Merger with a major/established bio-tech company like a BAYER, BIOGEN, NOVARTIS, etc.....3) Filing of their financials or 10K report........ Currently, this stock sits at .0011 per share
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up